Revance Therapeutics Inc (RVNC)
3.73
-0.11
(-2.86%)
USD |
NASDAQ |
Nov 22, 16:00
3.725
0.00 (0.00%)
Pre-Market: 20:00
Revance Therapeutics Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | -97.63M |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | -100.18M |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | -216.20M |
June 30, 2022 | -22.82M |
March 31, 2022 | -8.997M |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.001M |
June 30, 2021 | -0.001M |
March 31, 2021 | -21.71M |
December 31, 2020 | -68.37M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | -15.58M |
December 31, 2019 | -114.74M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | -108.10M |
December 31, 2018 | 0.00 |
Date | Value |
---|---|
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | -157.47M |
September 30, 2017 | -9.66M |
June 30, 2017 | -2.883M |
March 31, 2017 | -26.22M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | -126.10M |
September 30, 2015 | -10.15M |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.002M |
September 30, 2014 | 0.00 |
June 30, 2014 | -131.88M |
March 31, 2014 | -102.67M |
December 31, 2013 | |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-216.20M
Minimum
Sep 2022
0.001M
Maximum
Sep 2021
-33.31M
Average
-0.0005M
Median
Stock Buybacks (Quarterly) Benchmarks
Recursion Pharmaceuticals Inc | -16.97M |
Regeneron Pharmaceuticals Inc | 600.60M |
MEI Pharma Inc | -- |
GlycoMimetics Inc | 0.00 |
Anebulo Pharmaceuticals Inc | -- |